Sommaire

Numéro précédent | Numéro suivant

• Editorial

  • ·Introduction to the Special Issue on the A4 Study

    Page :801

    Paul Aisen, R. Sperling

    

• Original Research

  • ·Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

    Page :802-813

    Reisa A. Sperling, M.C. Donohue, R.A. Rissman, K.A. Johnson, D.M. Rentz, J.D. Grill, J.L. Heidebrink, C. Jenkins, G. Jimenez-Maggiora, O. Langford, A. Liu, R. Raman, R. Yaari, K.C. Holdridge, J.R. Sims, P.S. Aisen, A4 and LEARN Study Teams

    Résumé Résumé Plan Plan   
  • ·Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

    Page :814-822

    Dorene M. Rentz, P.B. Rosenberg, R.A. Sperling, M.C. Donohue, R. Raman, A. Liu, P.S. Aisen, A4 study team

    Résumé Résumé Plan Plan  
  • ·Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer’s Disease

    Page :823-830

    Robert A. Rissman, M.C. Donohue, O. Langford, R. Raman, S. Abdel-Latif, R. Yaari, K.C. Holdridge, J.R. Sims, D. Molina-Henry, G. Jimenez-Maggiora, K.A. Johnson, P.S. Aisen, R.A. Sperling, A4 and LEARN Study teams

    Résumé Résumé Plan Plan   
  • ·Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4

    Page :831-837

    Doris Molina-Henry, O. Langford, M.C. Donohue, R. Raman, P. Aisen, K.A. Johnson, R.A. Rissman, R. Sperling, A4 & LEARN Study Teams

    Résumé Résumé Plan Plan  
  • ·Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

    Page :838-845

    Rebecca E. Amariglio, J.D. Grill, D.M. Rentz, G.A. Marshall, M.C. Donohue, A. Liu, P.S. Aisen, R.A. Sperling, A4 Study team

    Résumé Résumé Plan Plan  
  • ·Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study

    Page :846-856

    Kathryn V. Papp, P. Maruff, D.M. Rentz, M.C. Donohue, A. Liu, P.S. Aisen, R.A. Sperling, A4 Study Team

    Résumé Résumé Plan Plan  
  • ·Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial

    Page :857-868

    Roy Yaari, K.C. Holdridge, M. Mancini, M.S. Rafii, M. Case, C. Battioui, J.R. Sims, P.S. Aisen, R.A. Sperling, A4 Study Team

    Résumé Résumé Plan Plan  
  • ·Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer’s Disease

    Page :869-873

    Zahra Shirzadi, A.P. Schultz, M. Properzi, R. Yaari, W.-Y. W. Yau, A.M. Brickman, M.S. Rafii, M.C. Donohue, K. Ernstrom, S. Wang, C.R. Jack, S.M. Greenberg, R. Raman, P. Aisen, R.A. Sperling, J.P. Chhatwal, A4 Study teams

    Résumé Résumé Plan Plan   
  • ·Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer’s Disease Randomized Controlled Trial

    Page :874-880

    Rema Raman, K. Hussen, M.C. Donohue, K. Ernstrom, K.C. Holdridge, O. Langford, D.P. Molina-Henry, A.L. Pierce, J.R. Sims, A. Smith, R. Yaari, P.S. Aisen, R. Sperling, J.D. Grill, A4 Study Team

    Résumé Résumé Plan Plan  
  • ·Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

    Page :881-888

    R. Boyle, H.M. Klinger, Z. Shirzadi, G.T. Coughlan, M. Seto, M.J. Properzi, D.L. Townsend, Z. Yuan, C. Scanlon, R.J. Jutten, K.V. Papp, R.E. Amariglio, D.M. Rentz, J.P. Chhatwal, M.C. Donohue, R.A. Sperling, A.P. Schultz, Rachel F. Buckley, A4 Study Team

    Résumé Résumé Plan Plan   
  • ·Maximizing the Utility of Alzheimer’s Disease Trial Data: Sharing of Baseline A4 and LEARN Data

    Page :889-894

    Gustavo A. Jimenez-Maggiora, A.P. Schulz, M.C. Donohue, H. Qiu, S.N. Jaiswal, O. Adegoke, R. Gallardo, O. Baryshnikava, R.A. Rissman, S. Abdel-Latif, R.A. Sperling, P.S. Aisen, A4 and LEARN Study Teams

    Résumé Résumé Plan Plan  

• Editorial

  • ·On the 2024 Alzheimer’s Association Criteria: Still Not Ready for Clinical Use

    Page :895-896

    Robin Ziyue Zhou, A. Wimo, B. Winblad

    Plan Plan

• Review

  • ·Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer’s Disease. Are We Ready for the New Era?

    Page :897-902

    Roxanna Korologou-Linden, J. Kalsi, D. Kafetsouli, A. Olawale, D. Wingfield, D. Mummery, B. Hayhoe, O. Robinson, A. Majeed, L.T. Middleton

    Résumé Résumé Plan Plan

• Brief Communication

  • ·Examining the Diagnostic Accuracy of a Novel Performance-Based Test for Alzheimer’s Disease Screening

    Page :903-907

    A.M. Reed, K. Duff, L.E. Dibble, S.S. Paul, A. Hooyman, Sydney Y. Schaefer

    Résumé Résumé Plan Plan

• Original Research

  • ·Predicting Cognitive Decline for Non-Demented Adults with High Burden of Tau Pathology, Independent of Amyloid Status

    Page :908-916

    H.-S. Wu, L. Li, Q.-Q. Sun, C.-C. Tan, L. Tan, Wei Xu, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Non-Genetic Risk Factors of Alzheimer’s Disease: An Updated Umbrella Review

    Page :917-927

    S.-Y. He, W.-M. Su, X.-J. Wen, S.-J. Lu, B. Cao, Bo Yan, Yong-Ping Chen

    Résumé Résumé Plan Plan   
  • ·Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment

    Page :928-942

    Sandar Aye, R. Handels, B. Winblad, L. Jönsson

    Résumé Résumé Plan Plan   
  • ·Predicting Brain Amyloid Status Using the National Institute of Health Toolbox (NIHTB) for Assessment of Neurological and Behavioral Function

    Page :943-957

    Y. Cheng, E. Ho, S. Weintraub, D. Rentz, R. Gershon, Sudeshna Das, Hiroko H. Dodge

    Résumé Résumé Plan Plan   
  • ·Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment

    Page :958-965

    Y. Wang, D. Ren, J.S. Roberts, L.K. Tamres, J.H. Lingler

    Résumé Résumé Plan Plan
  • ·Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment

    Page :966-974

    K.J. Mimmack, E.H. Sprague, R.E. Amariglio, P. Vannini, Gad A. Marshall, for the Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   

• Review

  • ·Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer’s Disease: A Systematic Review

    Page :975-982

    A. Patwardhan, T. Wilkinson, Y. Meng, I. Alhashyan, S.E. Black, N. Lipsman, Mario Masellis

    Résumé Résumé Plan Plan  

• Original Research

  • ·Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States

    Page :983-991

    Feride H. Frech, G. Li, T. Juday, Y. Ding, S. Mattke, A. Khachaturian, A.S. Rosenberg, C. Ndiba-Markey, A. Rava, R. Batrla, S. De Santi, H. Hampel

    Résumé Résumé Plan Plan   

• Brief Communication

  • ·Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved”

    Page :992-997

    Samuel P. Dickson, A. Solomon, M. Kivipelto, T. Hartmann, A M.J. van Hees, A. Brownlee, B. Haaland, C.H. Mallinckrodt, S.B. Hendrix

    Résumé Résumé Plan Plan  

• Review

  • ·Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis

    Page :998-1012

    F.O. de Andrade Santos, A.A. Passos, Ricardo Mario Arida, L. Teixeira-Machado

    Résumé Résumé Plan Plan   

• Original Research

  • ·Global Burden of Dementia Death from 1990 to 2019, with Projections to 2050: An Analysis of 2019 Global Burden of Disease Study

    Page :1013-1021

    Z. Li, N. Yang, L. He, J. Wang, Y. Yang, F. Ping, L. Xu, Huabing Zhang, Wei Li, Yuxiu Li

    Résumé Résumé Plan Plan   
  • ·Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels

    Page :1022-1029

    Soeren Mattke, Z. Shi, M. Hanson, S. Mitchell, C. Lynch, K. MacLean Kalonji, L. Lanman

    Résumé Résumé Plan Plan   
  • ·“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer’s Disease Progression

    Page :1030-1040

    S. Censi, C. Sestieri, M. Punzi, A. Delli Pizzi, A. Ferretti, F. Gambi, V. Tomassini, Stefano Delli Pizzi, Stefano L. Sensi, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-β42 over Amyloid Positron Emission Tomography

    Page :1041-1046

    J.-M. Pyun, M.J. Kang, S.J. Baek, K. Lee, Y.H. Park, SangYun Kim, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   

• Review

  • ·Association between Comorbidity Indices and Functional Autonomy in Individuals with Cognitive Impairment: A Systematic Review

    Page :1047-1054

    M.N. Temedda, A. Garnier-Crussard, C. Mouchoux, Virginie Dauphinot

    Résumé Résumé Plan Plan   

• Original Research

  • ·Prediction of Alzheimer’s Disease Based on 3D Genome Selected circRNA

    Page :1055-1062

    R. Chi, K. Li, K. Su, L. Liu, M. Feng, X. Zhang, J. Wang, X. Li, Guang He, Yi Shi

    Résumé Résumé Plan Plan  
  • ·Female Reproductive Factors and Risk of Mild Cognitive Impairment and Dementia: The HUNT Study

    Page :1063-1072

    Yehani Wedatilake, C. Myrstad, S.E. Tom, B.H. Strand, S. Bergh, G. Selbæk

    Résumé Résumé Plan Plan  

• Brief Communication

  • ·Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects

    Page :1073-1078

    G.M. Giuffrè, Davide Quaranta, M.G. Vita, E.M. Costantini, S. Citro, C. Carrozza, G. De Ninno, P. Calabresi, C. Marra

    Résumé Résumé Plan Plan  

• Original Research

  • ·Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging

    Page :1079-1086

    S.J. Feldman, D. Blasco, M. Mones, J. Scott Roberts

    Résumé Résumé Plan Plan
  • ·Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer’s Disease Neuroimaging Initiative Study

    Page :1087-1092

    Y. Wang, M. Ye, Q. Ji, Q. Liu, Xiaowei Xu, Yiqiang Zhan

    Résumé Résumé Plan Plan   
  • ·Biomarkers and Cognition Study, Singapore (BIOCIS): Protocol, Study Design, and Preliminary Findings

    Page :1093-1105

    Y.J. Leow, J.D.J. Wang, A. Vipin, G.K. Sandhu, S.A. Soo, D. Kumar, A.A. Mohammed, F.Z.B. Zailan, F.P.H.E. Lee, S. Ghildiyal, S.Y. Liew, C. Dang, P. Tanoto, I.Y.Z. Tan, W.F.W. Chong, Nagaendran Kandiah

    Résumé Résumé Plan Plan   
  • ·Alzheimer’s Disease Prediction Using Fly-Optimized Densely Connected Convolution Neural Networks Based on MRI Images

    Page :1106-1121

    R. Sampath, M. Baskar

    Résumé Résumé Plan Plan  
  • ·The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats

    Page :1122-1131

    Anna Thorsø Larsen, K.E. Mohamed, E.A. Petersen, M.A. Karsdal, K. Henriksen

    Résumé Résumé Plan Plan   
  • ·Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study

    Page :1132-1139

    D. Gao, W. Rong, C. Li, J. Liang, Y. Wang, Y. Pan, W. Zhang, Fanfan Zheng, Wuxiang Xie

    Résumé Résumé Plan Plan   
  • ·Association between Resting Heart Rate and Machine Learning-Based Brain Age in Middle- and Older-Age

    Page :1140-1147

    J. Wang, H. Huang, W. Yang, A. Dove, Xiangyu Ma, Weili Xu

    Résumé Résumé Plan Plan   

• Review

  • ·Periodontal Disease and Alzheimer’s: Insights from a Systematic Literature Network Analysis

    Page :1148-1165

    Alice Villar, S. Paladini, J. Cossatis

    Résumé Résumé Plan Plan  

• Original Research

  • ·The Shape Trail Test Is Sensitive in Differentiating Older Adults with Mild Cognitive Impairment: A Culture-neutral Five-minute Test

    Page :1166-1176

    Z. Ding, Agnes S. Chan

    Résumé Résumé Plan Plan   

• Letter to the Editor

  • ·Hypnotics and Incident Dementia: A Risk Assessment

    Page :1177

    Tomoyuki Kawada

    
  • ·Update to: Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease

    Page :1178-1179

    C. Rubel, T. Chen, Gersham Dent